Entacapone (KAISER FOUNDATION HOSPITALS)


Welcome to the PulseAid listing for the Entacapone drug offered from KAISER FOUNDATION HOSPITALS. This Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: KAISER FOUNDATION HOSPITALS
NON-PROPRIETARY NAME: Entacapone
SUBSTANCE NAME: ENTACAPONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2014-10-10
END MARKETING DATE: 0000-00-00


Entacapone HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEntacapone from KAISER FOUNDATION HOSPITALS
LABELER NAME: KAISER FOUNDATION HOSPITALS
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2014-10-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0179-0166_86d22c23-5caf-4297-8658-1a6c223abe87
PRODUCT NDC: 0179-0166
APPLICATION NUMBER: NDA020796

Other ENTACAPONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Ajanta Pharma LimitedEntacapone
American Health PackagingEntacapone
Aphena Pharma Solutions – Tennessee, LLCEntacapone
Aurobindo Pharma LimitedEntacapone
Avera McKennan HospitalEntacapone
AvKARE, Inc.Entacapone
AvPAKEntacapone
Cardinal HealthComtan
KAISER FOUNDATION HOSPITALSEntacapone
Macleods Pharmaceuticals LimitedEntacapone
Mylan Institutional Inc.Entacapone
Mylan Pharmaceuticals Inc.Entacapone
Novartis Pharmaceuticals CorporationComtan
Sandoz IncEntacapone
Sun Pharma Global FZEEntacapone
Wockhardt LimitedEntacapone
Wockhardt USA LLC.Entacapone